The FDA's GRAS status allows supplements to bypass full review, a point targeted by Kennedy and analyzed by experts like Professor Cohen, involving Calley Means and Harvard Medical School.
2 reports, 2 independent
Updated Jul 30
Gone quiet
- Reports
- 2
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA's GRAS status allows supplements to bypass full review, a point targeted by Kennedy and analyzed by experts like Professor Cohen, involving Calley Means and Harvard Medical School.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Cohen critiques FDA testing standards regarding product review.1 source
- APA research informs expert critique of the institutional review process regarding GRS's status.Sub-event
Kennedy targets the FDA's GRAS loophole allowing supplements to bypass full review, with expert analysis from Harvard Medical School.1 source
Keep exploring
The entities involved
- FDA
-
Consumer Healthcare Products Association
organization
-
Calley Means
American entrepreneur (born 1985)
Nothing else this week.
-
Harvard Medical School
medical school in Boston, Massachusetts
Related events
- The FDA is accused of failing to enforce safety regulations and operating under current rules without in-person oversight.
- Unregulated products are bypassing official government approval processes.
- The FDA is facing public scrutiny due to oversight failures, leading to the introduction of new legislation targeting agency shortcomings.
- FDA seeks to ease market restrictions while consumer companies Ferrara and Hershey innovate in premium product lines.
- The FDA was tasked to review product licenses and public health warnings.